Dermatology NewsEmployed physicians: A survival guideOctober 19, 2023Business of MedicinePractice Management
Dermatology NewsFDA approves bimekizumab for moderate to severe plaque psoriasis in adultsOctober 19, 2023PsoriasisPsoriatic Arthritis
Dermatology NewsOnce-weekly topical therapy shows promise for moderate to severe acneOctober 19, 2023AcnePediatrics
Dermatology NewsArtificial intelligence in the office: Part 2October 19, 2023Business of MedicineMixed Topics
Dermatology NewsAI chatbot ‘hallucinates’ faulty medical intelligenceOctober 19, 2023Infectious DiseasesMixed Topics
Dermatology NewsPilot study: High-dose IL-23 inhibition shows promise for psoriasis remission in some patientsOctober 19, 2023PsoriasisPsoriatic Arthritis
Dermatology NewsPrior authorization software: Saves time but hurdles remainOctober 18, 2023Business of MedicinePractice Management
No association between atopic dermatitis and non-alcoholic fatty liver diseaseOctober 18, 2023Atopic Dermatitis
Dupilumab shows long-term safety and efficacy in severe pediatric atopic dermatitisOctober 18, 2023Atopic Dermatitis
Tralokinumab improves clinical responses at week 16 in moderate-to-severe AD despite IGA 0/1 nonachievementOctober 18, 2023Atopic Dermatitis
Methotrexate reduces epidermal hyperplasia and alters cutaneous IL-31 and IL-31RA expression in ADOctober 18, 2023Atopic Dermatitis
Tacrolimus tops hydrocortisone in pediatric atopic dermatitis treatmentOctober 18, 2023Atopic Dermatitis
Atopic dermatitis affects outcomes in occupational contact dermatitisOctober 18, 2023Atopic Dermatitis
Xyloglucan-pea protein a possible steroid-sparing alternative for treating pediatric ADOctober 18, 2023Atopic Dermatitis
